Overactive bladder drug wins OTC approval, but only for women

01/28/2013 | Reuters · MedPage Today (free registration)

Merck & Co. obtained FDA approval to market an over-the-counter version of Oxytrol for women ages 18 and older with overactive bladder. The OTC product, which will be sold as Oxytrol for Women, is a patch that contains oxybutynin, an anticholinergic agent that helps relax the bladder muscle. Men will continue to need a prescription to buy the drug. Prostate cancer diagnosis could be delayed if men mistake the cause of their urination problems.

View Full Article in:

Reuters · MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Senior Manager, Compliance
Stryker
Fremont, CA
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA